BioMark Diagnostics, Inc. · CSE:BUX

BioMark Diagnostics, Inc. financial statements

BioMark Diagnostics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CAD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue59.8K154.2K163.2K153.5K43.9K0263.3K000
Cost of revenue00
Gross profit00
Research and development667.8K696.0K650.5K545.8K497.8K118.4K42.3K56.4K58.2K52.0K
Selling, general and administrative547.2K1.19M926.2K1.15M863.9K961.5K1.42M489.2K668.5K669.1K
Operating income-1.46M-2.14M-1.61M-1.93M-1.40M-1.08M-1.21M-545.6K-726.7K-721.0K
Depreciation and amortization382.3K401.3K393.2K386.2K179.6K13.7K11.9K11.9K11.9K11.9K
EBITDA-1.07M-1.74M-1.22M-1.55M-1.22M-1.07M-1.20M-533.7K-714.8K-709.1K
Interest expense63.3K61.5K115.2K110.2K49.7K4.14K2.39K000
Income before tax-1.48M-1.93M-1.43M-1.84M-1.45M-1.09M-1.22M-545.6K-726.7K-715.4K
Income tax00
Net income-1.48M-1.93M-1.43M-1.84M-1.45M-1.09M-1.22M-545.6K-726.7K-715.4K
Earnings per share, basic-0.01-0.02-0.02-0.02-0.02-0.01-0.02-0.01-0.01-0.01

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents619.1K2.48M156.7K72.0K382.7K877.7K611.8K20.0K36.6K17.5K
Short-term investments391.8K0
Receivables50.3K160.7K43.0K34.4K82.1K27.2K16.1K12.6K13.3K22.1K
Current assets1.08M2.64M199.8K126.3K499.0K923.0K627.9K33.0K50.1K39.6K
Property, plant and equipment454.1K851.8K588.5K969.4K26.7K9.38K1.64K1.64K
Total assets1.86M3.13M1.09M732.3K1.47M952.9K637.3K34.6K51.7K39.6K
Accounts payable100.7K267.5K144.4K220.2K128.3K27.1K111.8K163.9K160.4K368.1K
Current liabilities1.10M1.23M1.24M1.66M1.50M922.4K1.08M1.25M952.2K1.10M
Long-term debt096.3K91.6K
Total debt109.6K
Total liabilities1.53M1.39M1.70M1.88M2.11M1.03M1.08M1.25M952.2K1.10M
Shareholders' equity331.1K1.74M-609.6K-1.15M-635.7K-79.1K-439.1K-1.22M-900.4K-1.07M
Shares outstanding105.1M105.1M90.9M83.3M78.0M76.8M72.3M65.0M62.8M54.4M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-1.09M-1.09M-982.5K-914.4K-1.20M-807.3K-453.8K-277.8K-770.4K-109.5K
Capital spending-4.23K-3.53K-4.39K-5.30K-59.2K-59.2K-790-790-1.64K-1.64K
Free cash flow-1.09M-1.10M-986.9K-919.7K-1.26M-455.6K-454.6K-277.8K-772.1K-111.2K
Cash from investing-3.53K-4.39K-5.30K-59.2K-3.20K-790-790-1.64K-1.64K
Cash from financing-377.8K3.42M1.07M609.0K768.2K1.08M1.05M261.2K791.2K112.9K
Share buybacks3.61M1.54M640.7K235.0K911.1K871.6K222.1K753.2K147.6K
Change in cash-1.86M2.33M84.7K-310.7K-495.0K265.9K591.8K-16.6K19.1K3.36K